Matt Larew
Stock Analyst at William Blair
(4.10)
# 1,489
Out of 4,547 analysts
188
Total ratings
55.6%
Success rate
9.3%
Average return
Main Sectors:
Stocks Rated by Matt Larew
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TEM Tempus AI | Rated: Hold | n/a | $48.98 | - | 1 | Jul 21, 2026 | |
| CDNA CareDx | Maintained: Hold | n/a | $38.54 | - | 1 | Jul 16, 2026 | |
| QGEN Qiagen | Rated: Hold | n/a | $40.53 | - | 1 | Jul 10, 2026 | |
| GH Guardant Health | Maintained: Buy | n/a | $152.29 | - | 1 | Jul 10, 2026 | |
| STVN Stevanato Group | Maintained: Buy | n/a | $19.10 | - | 12 | Jul 9, 2026 | |
| MXCT MaxCyte | Rated: Hold | n/a | $1.23 | - | 10 | Jul 2, 2026 | |
| TECH Bio-Techne | Downgraded: Hold | n/a | $71.63 | - | 8 | Jun 27, 2026 | |
| TMO Thermo Fisher Scientific | Reiterated: Buy | n/a | $523.46 | - | 10 | Jun 12, 2026 | |
| OPCH Option Care Health | Maintained: Buy | n/a | $21.67 | - | 12 | Jun 1, 2026 | |
| TWST Twist Bioscience | Reiterated: Buy | n/a | $95.86 | - | 10 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $359.24 | - | 11 | May 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $136.99 | - | 9 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $7.89 | - | 12 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $47.20 | - | 9 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $7.10 | - | 13 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $5.34 | - | 8 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $7.35 | - | 13 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $367.55 | - | 5 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $119 | $128.91 | -7.69% | 12 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $10.99 | - | 8 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $179.01 | - | 8 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $219.40 | - | 1 | Oct 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $74.74 | n/a | 4 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $16.28 | n/a | 1 | Aug 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $11.84 | n/a | 2 | Sep 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $237.28 | n/a | 4 | Sep 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $279.40 | n/a | 1 | Dec 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $112.10 | n/a | 1 | Nov 21, 2017 |
Tempus AI
Jul 21, 2026
Rated: Hold
Price Target: n/a
Current: $48.98
Upside: -
CareDx
Jul 16, 2026
Maintained: Hold
Price Target: n/a
Current: $38.54
Upside: -
Qiagen
Jul 10, 2026
Rated: Hold
Price Target: n/a
Current: $40.53
Upside: -
Guardant Health
Jul 10, 2026
Maintained: Buy
Price Target: n/a
Current: $152.29
Upside: -
Stevanato Group
Jul 9, 2026
Maintained: Buy
Price Target: n/a
Current: $19.10
Upside: -
MaxCyte
Jul 2, 2026
Rated: Hold
Price Target: n/a
Current: $1.23
Upside: -
Bio-Techne
Jun 27, 2026
Downgraded: Hold
Price Target: n/a
Current: $71.63
Upside: -
Thermo Fisher Scientific
Jun 12, 2026
Reiterated: Buy
Price Target: n/a
Current: $523.46
Upside: -
Option Care Health
Jun 1, 2026
Maintained: Buy
Price Target: n/a
Current: $21.67
Upside: -
Twist Bioscience
May 26, 2026
Reiterated: Buy
Price Target: n/a
Current: $95.86
Upside: -
May 20, 2026
Maintained: Buy
Price Target: n/a
Current: $359.24
Upside: -
May 14, 2026
Maintained: Buy
Price Target: n/a
Current: $136.99
Upside: -
May 11, 2026
Reiterated: Sell
Price Target: n/a
Current: $7.89
Upside: -
May 8, 2026
Maintained: Buy
Price Target: n/a
Current: $47.20
Upside: -
May 8, 2026
Maintained: Hold
Price Target: n/a
Current: $7.10
Upside: -
May 7, 2026
Maintained: Buy
Price Target: n/a
Current: $5.34
Upside: -
May 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $7.35
Upside: -
May 5, 2026
Maintained: Buy
Price Target: n/a
Current: $367.55
Upside: -
May 1, 2026
Rated: Hold
Price Target: $119
Current: $128.91
Upside: -7.69%
Apr 29, 2026
Maintained: Hold
Price Target: n/a
Current: $10.99
Upside: -
Apr 22, 2026
Maintained: Buy
Price Target: n/a
Current: $179.01
Upside: -
Oct 11, 2025
Upgraded: Buy
Price Target: n/a
Current: $219.40
Upside: -
Oct 8, 2024
Reiterated: Hold
Price Target: n/a
Current: $74.74
Upside: n/a
Aug 22, 2022
Maintained: Buy
Price Target: n/a
Current: $16.28
Upside: n/a
Sep 22, 2021
Downgraded: Hold
Price Target: n/a
Current: $11.84
Upside: n/a
Sep 11, 2019
Downgraded: Hold
Price Target: n/a
Current: $237.28
Upside: n/a
Dec 3, 2018
Maintained: Buy
Price Target: n/a
Current: $279.40
Upside: n/a
Nov 21, 2017
Initiated Coverage: Buy
Price Target: n/a
Current: $112.10
Upside: n/a